Found 0 matching trials
Estradiol Levels in Patients Treated With Estring PHASE2 Estrogen receptor positive breast cancer is the most common type of breast ...
Show More Location
University of Arizona
Learn More & Join Trial
Trial of Fulvestrant, MK-0646, and Dasatinib for Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer PHASE1 The goals of this clinical research study are to learn the tolerable and ef...
Show More Location
UT MD Anderson Cancer Center
Learn More & Join Trial
Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer PHASE2 Primary Objective:
To determine whether amcenestrant per overall survival ...
Show More Location
Alabama Oncology - St. Vincent's Birmingham- Site Number : 8400008
Learn More & Join Trial
Neo-Adjuvant Abemaciclib With Fulvestrant in Patients With ER/PR +HER Negative Breast Cancer PHASE2 This is a phase 2 single-arm, open-label determining efficacy of Neo-adjuva...
Show More Location
Chao Family Comprehensive Cancer Center, University of California, Irvine
Learn More & Join Trial
A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale PHASE2 This is a 4-arm study to evaluate and compare bleeding patterns between thr...
Show More Location
Duramed Investigational Site
Learn More & Join Trial
Treatment Patterns and Clinical Outcomes Among Patients Receiving Palbociclib Combinations for Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2 ) Advanced/Metastatic Breast Cancer in the Arabian Gulf Region N/A retrospective non-interventional study (NIS) that aims to describe the demo...
Show More Location
Hamad Medical Corporation
Learn More & Join Trial
Study of PF-07248144 in Advanced or Metastatic Solid Tumors PHASE2 This is an open-label, multi center study to evaluate safety, tolerability,...
Show More Learn More & Join Trial
Estradiol and Intrusive Memories NA The aim of the current project is to investigate the impact of 3mg of oral ...
Show More Location
Charité - Universitätsmedizin Berlin
Learn More & Join Trial
Combined Hormone Therapy, C-reactive Protein(CRP) Levels and Life Quality in Natural Menopause Women N/A This study aims to assess the effect of low dose combined estradiol and nor...
Show More Location
Multiple Locations
Learn More & Join Trial
Heart and Estrogen-Progestin Replacement Study (HERS) PHASE3 The purpose of the study is to determine whether hormone replacement therap...
Show More Location
University of California San Francisco
Learn More & Join Trial